Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma
Status:
Withdrawn
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the effect of chemotherapy on decreasing the size of
unresectable pancreas cancer thereby allowing it to be surgically removed. In addition, this
study may provide information on how tumors behave when exposed to certain types of
chemotherapy.